Greg Bonfigliogre

Greg Bonfiglio

Founder & Managing Partner
Proteus Venture Partners, USA

Mr. Bonfiglio received his B.A. in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D. (magna cum laude) from the University of Michigan Law School in 1981.

Mr. Bonfiglio is the Founder & Managing Partner of Proteus, LLC – an investment and advisory firm focused solely on regenerative medicine.  Proteus provides fund management, consulting, and investment banking services to the regenerative medicine industry.

Mr. Bonfiglio was an early investor in the field of stems cell & regenerative medicine, and he continues to be actively involved in the field.  He is a frequent speaker at Regenerative Medicine Conferences.  Mr. Bonfiglio is a Member of the ISSCR and is on their Advisory Board, as well as their Finance Committee.  He also is a Member of the ISCT and is on their Commercialization Committee.   Mr. Bonfiglio is on the Boards of VistaGen Therapeutics (in vitro tools from hESCs);  StemCyte, Inc. (cord blood storage & therapeutics); and California Stem Cell, Inc. (reagents & CNS therapeutics from hESCs).

Mr. Bonfiglio has over 25 years experience working with technology companies.    From 2000 – 2005, Mr. Bonfiglio was a General Partner with Anthem Venture Partners – an early stage venture fund in California.    While at Anthem, Mr. Bonfiglio led investments in both biotechnology and IT.  Anthem generated top quartile returns for its investors.

Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients.   Mr. Bonfiglio was an Adjunct Professor of Law at Stanford Law School, from 1996 to 2000.   Since 1995, he has been a regular Guest Lecturer at the UC Berkley Haas Business School, in the Top Down Law program.

Mr. Bonfiglio lives in Portola Valley where he coaches basketball and baseball, and is actively involved in the community.

Return to Board of Directors

Subscribe to our mailing list to receive CCRM’s monthly newsletter.


You have Successfully Subscribed!